Today: 20 June 2026

AMD Stock After Hours Today (Dec. 23, 2025): China MI308 Buzz, Tariff Headlines, and What to Know Before Markets Open Dec. 24

AMD Stock After Hours Today (Dec. 23, 2025): China MI308 Buzz, Tariff Headlines, and What to Know Before Markets Open Dec. 24

AMD closed Tuesday down 0.36% at $214.18 after trading in a narrow range, with about 14.34 million shares exchanged. After-hours trading showed little change. Market focus centered on reports that Alibaba may buy up to 50,000 China-compliant MI308 AI accelerators, which could add $500 million to $800 million in AMD revenue if realized, according to Raymond James.
23 December 2025
·
Oracle Stock After Hours Today (Dec. 23, 2025): ORCL Closes Near $195 as AI Debt and Accounting Headlines Dominate — What to Watch Before Tomorrow’s Early Close

Oracle Stock After Hours Today (Dec. 23, 2025): ORCL Closes Near $195 as AI Debt and Accounting Headlines Dominate — What to Watch Before Tomorrow’s Early Close

Oracle shares closed Tuesday at $195.14, down 1.63%, then traded flat after hours. Volume reached 15.14 million shares, with prices ranging from $192.19 to $197.20. Trading remained muted ahead of Wednesday’s early market close for the holiday. Investors continue to weigh Oracle’s AI cloud growth against concerns over spending and accounting.
23 December 2025
··
Amazon Stock After Hours Today (Dec. 23, 2025): AMZN Holds Near $232 After the Bell — Key News, Forecasts, and What to Watch Before the Dec. 24 Market Open

Amazon Stock After Hours Today (Dec. 23, 2025): AMZN Holds Near $232 After the Bell — Key News, Forecasts, and What to Watch Before the Dec. 24 Market Open

Amazon closed at $232.14 on Tuesday, up 1.62% from Monday, then edged to $232.15 in early after-hours trading. The stock traded between $228.73 and $232.45 during the session. Market cap stood near $2.48 trillion, with shares about 10% below the 52-week high. Investors weighed a Zoox recall, AWS legal news, and macro data as trading slowed for the holiday week.
23 December 2025
··
Microsoft Stock After Hours: MSFT Ends Dec. 23, 2025 Higher as AI Trade Stabilizes — What to Watch Before the Dec. 24 Market Open

Microsoft Stock After Hours: MSFT Ends Dec. 23, 2025 Higher as AI Trade Stabilizes — What to Watch Before the Dec. 24 Market Open

Microsoft shares closed at $486.85 Tuesday, up 0.40%, then edged down 0.01% to $486.79 in after-hours trading. Volume was light ahead of the Christmas holiday. The stock tracked broader market gains after upbeat U.S. GDP data. Investors are watching thin holiday liquidity and renewed focus on AI spending.
23 December 2025
···
Meta Platforms (META) Stock After Hours Today (Dec. 23, 2025): What’s Driving the Move and What to Watch Before the Market Opens Dec. 24

Meta Platforms (META) Stock After Hours Today (Dec. 23, 2025): What’s Driving the Move and What to Watch Before the Market Opens Dec. 24

Meta closed Tuesday near $665, trading between $658 and $666 on light volume of about 5.6 million shares, well below its average. After hours, the stock was little changed as markets absorbed a slight price target cut from Baird, which maintained an Outperform rating. Holiday-thinned trading continued to limit activity.
23 December 2025
·
Nvidia Stock (NVDA) After Hours: Dec. 23, 2025 Close, China H200 Headlines, Analyst Targets, and What to Watch Before Dec. 24 Market Open

Nvidia Stock (NVDA) After Hours: Dec. 23, 2025 Close, China H200 Headlines, Analyst Targets, and What to Watch Before Dec. 24 Market Open

Nvidia shares closed at $189.18 on Tuesday, up about 3%, then traded flat after hours. The session followed a rally in U.S. growth stocks and renewed attention on U.S.-China chip policy. Trading volume reached roughly 135.8 million shares. U.S. markets will close early Wednesday for Christmas Eve, with thin liquidity expected.
23 December 2025
··
Tesla Stock (TSLA) After Hours Today, Dec. 23, 2025: Why Shares Fell Back From $500 — and What to Watch Before the Market Opens Christmas Eve

Tesla Stock (TSLA) After Hours Today, Dec. 23, 2025: Why Shares Fell Back From $500 — and What to Watch Before the Market Opens Christmas Eve

Tesla shares closed at $486.32 Tuesday, down 0.49%, after trading between $482.84 and $491.97 with 47.9 million shares exchanged. Early after-hours trading kept TSLA near $485.50. European data showed Tesla registrations fell 11.8% in November while BYD surged. Analysts expect Q4 deliveries below consensus, citing weaker U.S. demand after tax credits expired.
23 December 2025
··
Adobe Stock (ADBE) News Today: AI Video Push, Legal Overhang, and Wall Street Forecasts on Dec. 23, 2025

Adobe Stock (ADBE) News Today: AI Video Push, Legal Overhang, and Wall Street Forecasts on Dec. 23, 2025

Adobe shares fell 1.66% Tuesday, closing at $351.60 after trading between $350.58 and $359.67. The drop followed new legal developments and ongoing debate over Adobe’s ability to convert AI advances into lasting revenue. Fiscal 2025 results showed Q4 revenue of $6.19 billion and net income of $1.86 billion, but investor skepticism persists amid AI-driven competition and regulatory concerns.
23 December 2025
··
Sunrun (RUN) Stock News Today: Insider Sale, Clear Street Raises Target, and the Solar Tax Credit Deadline Driving Volatility (Dec. 23, 2025)

Sunrun (RUN) Stock News Today: Insider Sale, Clear Street Raises Target, and the Solar Tax Credit Deadline Driving Volatility (Dec. 23, 2025)

Sunrun shares fell 3.2% to $19.59 on Dec. 23 after an 11% surge the previous day, as markets reacted to insider-sale headlines and a looming U.S. solar tax-credit deadline. Director Edward Harris Fenster sold 32,787 shares under a pre-set plan, according to SEC filings. Clear Street raised its price target to $23, keeping a Buy rating. Sunrun’s market cap stood at $4.5 billion.
23 December 2025
Dominion Energy Stock (NYSE: D) Rebounds on Dec. 23, 2025: Offshore Wind Pause, CVOW Outlook, and Analyst Forecasts

Dominion Energy Stock (NYSE: D) Rebounds on Dec. 23, 2025: Offshore Wind Pause, CVOW Outlook, and Analyst Forecasts

Dominion Energy shares rose 1.7% to $58.18 Tuesday after rebounding from losses triggered by the Trump administration’s suspension of leases for five major offshore wind projects, including Dominion’s Coastal Virginia Offshore Wind. The stock had fallen up to 6% Monday on the news. The company warned the 90-day halt threatens grid reliability and energy supply for Virginia. Trading volume topped 5 million shares.
23 December 2025
··
Applied Materials Stock (AMAT) News and Forecasts for Dec. 23, 2025: Analyst Price Targets Rise on AI Memory Boom, China Risk Still Looms

Applied Materials Stock (AMAT) News and Forecasts for Dec. 23, 2025: Analyst Price Targets Rise on AI Memory Boom, China Risk Still Looms

Applied Materials shares traded near $259 on December 23, 2025, close to their 52-week high of $276. Analyst opinions remain mixed, with Seeking Alpha and Zacks both maintaining “Hold” ratings due to China risks, while Trefis issued a “sell” call and a $182 downside scenario. The stock has gained 12.2% over the past month. Investors are watching for memory-driven spending in 2026.
23 December 2025
·
Daqo New Energy (DQ) Stock Drops on Dec. 23, 2025: Today’s News, Analyst Forecasts, and the Key Polysilicon Drivers to Watch

Daqo New Energy (DQ) Stock Drops on Dec. 23, 2025: Today’s News, Analyst Forecasts, and the Key Polysilicon Drivers to Watch

Daqo New Energy shares dropped about 5% to $31.35 in light trading Tuesday, with no new company news released. Options activity flagged by Benzinga showed bearish sentiment during the session. Analyst views diverged, with Seeking Alpha citing oversupply risks and Daiwa maintaining an Outperform rating on long-term value.
23 December 2025
··
AbbVie (ABBV) Stock News Today, Dec. 23, 2025: Beyond Botox Pipeline Push, Analyst Targets, and What to Watch Next

AbbVie (ABBV) Stock News Today, Dec. 23, 2025: Beyond Botox Pipeline Push, Analyst Targets, and What to Watch Next

AbbVie shares traded near $228.62 Tuesday afternoon, up 0.31%, as investors weighed new pipeline updates and continued debate over U.S. drug pricing. PharmaVoice reported AbbVie is advancing two next-generation neurotoxins, AGN-151607 and TrenibotE, for both aesthetic and therapeutic uses. Nasdaq highlighted strong Skyrizi and Rinvoq sales, projecting over $25 billion combined in 2025.
23 December 2025
·
Netskope Stock (NASDAQ: NTSK) Slides on Dec. 23, 2025: What’s Driving the Move, Fresh Earnings Context, and Wall Street Forecasts

Netskope Stock (NASDAQ: NTSK) Slides on Dec. 23, 2025: What’s Driving the Move, Fresh Earnings Context, and Wall Street Forecasts

Netskope shares fell about 5.7% Tuesday to $18.58, underperforming a bullish U.S. market. The drop followed light early trading and comes after a volatile December, with the stock down sharply since its first post-IPO earnings. Netskope reported Q3 revenue of $184.2 million, up 33% year over year.
23 December 2025
···
CrowdStrike Stock (CRWD) News Today: AI Security Push, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

CrowdStrike Stock (CRWD) News Today: AI Security Push, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

CrowdStrike shares traded near $478 on Dec. 23, down about 1% amid a tight intraday range. The company recently launched Falcon AI Detection and Response, targeting enterprise AI security. Analysts say strong fundamentals persist, but investors remain cautious about high valuations in a selective market. No new earnings were reported Tuesday.
23 December 2025
···
1 … 1,229 1,230 1,231 1,232 1,233 … 2,086

Stock Market Today

  • AstraZeneca Fair Value Slightly Lower Amid Pipeline and Pricing Debates
    June 19, 2026, 10:35 PM EDT. AstraZeneca's (LSE:AZN) fair value estimate edged down slightly from £165.09 to £164.85, reflecting cautious shifts in valuation due to regulatory and pricing factors. Major analysts including Citi and Morgan Stanley raised price targets, supporting the current valuation on hopes for long-term growth and pipeline strength. However, Jefferies highlighted execution risks after a negative FDA advisory for the SERENA 6 oncology drug and noted competitive pressures on the newly approved Baxfendy therapy. Recent U.S. FDA approval of TRUQAP for prostate cancer and a planned US$50 billion investment to boost U.S. manufacturing and R&D underscore AstraZeneca's growth strategy. Investors weigh bullish optimism against highlighted risks as AstraZeneca targets US$80 billion revenue by 2030.

Latest articles

JBS shutdowns put pressure on U.S. beef as cattle prices rise

JBS shutdowns put pressure on U.S. beef as cattle prices rise

20 June 2026
JBS USA will close its Souderton, PA, and Memphis, TN, meat plants on August 14, cutting 1,693 jobs as tight cattle supplies drive negative U.S. beef margins; USDA data show beef prices up 14.8% year-over-year and forecast to rise another 12.1% in 2026, signaling ongoing cost pressure for packers and consumers.
TSMC Leads Nvidia in Short Week Chip Gains

TSMC Leads Nvidia in Short Week Chip Gains

20 June 2026
TSMC’s U.S.-listed shares soared 6.9% to $462.12, outpacing Nvidia’s 3.0% gain, as investors favored broad chip manufacturing exposure after an interim U.S.-Iran deal eased inflation fears and Taiwan’s central bank raised its 2026 economic-growth forecast to 9.45% on AI-driven semiconductor demand.
Intel Beats AMD for Week After Trump Comments on Apple Chips

Intel Beats AMD for Week After Trump Comments on Apple Chips

20 June 2026
Intel soared 10.6% to a record $133.99 after President Trump said Apple agreed to work with Intel on U.S. chip design and production, though neither company confirmed terms or details; analysts are split on the deal’s value, with Intel’s gains outpacing AMD’s 4.9% rise as the chip sector hit a record close.
Go toTop